RIVASTIGMINE TARTRATE (Nivagen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the RIVASTIGMINE TARTRATE drug offered from Nivagen Pharmaceuticals, Inc.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Nivagen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | RIVASTIGMINE TARTRATE |
SUBSTANCE NAME: | RIVASTIGMINE TARTRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-09-04 |
END MARKETING DATE: | 0000-00-00 |
RIVASTIGMINE TARTRATE HUMAN PRESCRIPTION DRUG Details:
Item Description | RIVASTIGMINE TARTRATE from Nivagen Pharmaceuticals, Inc. |
LABELER NAME: | Nivagen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4.5(mg/1) |
START MARKETING DATE: | 2017-09-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 75834-135_1fcff583-3008-4d25-8fb4-c09454797304 |
PRODUCT NDC: | 75834-135 |
APPLICATION NUMBER: | ANDA203844 |
Other RIVASTIGMINE TARTRATE Pharmaceutical Manufacturers / Labelers: